Healthcare (Public Health)

HB 2133 modernizes Oklahoma's prescribing rules for healthcare providers and controlled substances. It allows pharmacists to fill non-controlled prescriptions from out-of-state advanced practice nurses or physician assistants (if licensed in their home state), but restricts out-of-state prescribers from writing prescriptions for controlled dangerous substances - only Oklahoma-licensed practitioners supervised by Oklahoma physicians can do this. The bill also requires medical facilities prescribing opioids, benzodiazepines, or similar drugs long-term to register with the state, and mandates detailed monthly reporting for manufacturers/distributors of controlled substances. These changes directly affect pharmacists, out-of-state healthcare providers, medical facilities, and drug manufacturers.

SB 1299 requires Oklahoma's Department of Human Services to seek a federal waiver allowing restrictions on SNAP benefits for certain foods (like sugary drinks or junk food) to improve nutrition and program efficiency. It directly affects SNAP recipients in Oklahoma by potentially limiting which foods they can purchase with their benefits. The bill mandates the department submit a detailed waiver request - including public health justification, retailer system plans, recipient education strategies, and impact tracking - within 60 days if initially denied. If approved, restrictions must be implemented within six months, and the department must provide annual reports on waiver status, spending patterns, and challenges to state leaders.

HB 2033 creates a revolving fund called the "Community Health Center Access to Care Revolving Fund" within Oklahoma's State Department of Health. The fund, not limited by fiscal years, will use appropriated monies to increase access to care at federally authorized community health centers (as defined under 42 U.S.C. §330). The Department of Health can spend these funds to support such centers, with expenditures requiring State Treasurer warrants based on approved claims. The bill takes effect July 1, 2025, and was declared an emergency to allow immediate implementation.

HB 1019 creates the Oklahoma Rare Disease Advisory Council within the State Department of Health to address the needs of Oklahomans with rare diseases. The council, composed of 15 members including patients, caregivers, medical professionals, industry representatives, and health officials, will provide recommendations on healthcare access, emergency planning, and research. It must submit annual reports to the Legislature and Governor, including public comment periods, and hold quarterly meetings with public input opportunities. The council will operate starting February 2026, with members serving up to four years during the initial staggered rollout. This bill directly affects rare disease patients, caregivers, and healthcare providers across Oklahoma by establishing a formal advisory body to guide state policy.

HB 2012 removes the July 1, 2026, expiration date for Oklahoma's harm-reduction services program, making it permanent. It authorizes government agencies, religious institutions, nonprofits, for-profit companies, and tribal governments to provide services including needle distribution, HIV/hepatitis testing, referrals for addiction treatment, and safe needle disposal. Providers must register with the State Department of Health and report quarterly on services delivered, such as the number of people served, needles distributed, and test results. This bill directly affects people who use injection drugs by expanding access to health services aimed at reducing disease transmission and overdose risks.